Registrar Corp Registrar Corp LinkedIn Registrar Corp Twitter Registrar Corp Facebook Registrar Corp Google+ Registrar Corp Youtube Channel Registrar Corp FDA News Blog
HomeDrugsU.S. FDA Active Pharmaceutical Ingredients (API)API Examples › U.S. FDA Regulations: Acetazolamide

U.S. FDA Requirements: Acetazolamide

Pharmaceutical / Drug Definition : Inhibits carbonic anhydrase in kidney, decreasing water reabsorption and increasing excretion of sodium, potassium, and bicarbonate. Lowers intraocular pressure by decreasing aqueous humor production. May raise seizure threshold by reducing carbonic anhydrase in CNS, thereby decreasing neuronal conduction

Registrar Corp assists Acetazolamide companies with:

  • FDA Registration Acetazolamide
  • FDA Listing Acetazolamide
  • FDA Label Requirements and Exceptions Acetazolamide
  • FDA Import Information Acetazolamide
  • FDA Detentions Acetazolamide (Acetazolamide Entry Refusal)
  • General U.S. Food and Drug Administration Guidelines for:
       - Manufacturers Acetazolamide (Acetazolamide Suppliers)
       - Processors Acetazolamide
       - Repackers Acetazolamide
       - Relabelers Acetazolamide
       - Exporters Acetazolamide
       - Importers Acetazolamide
For more information about Acetazolamide, simply click below:




Live Help

 
U.S. FDA Regulations:

U.S. FDA Regulation: 21 C.F.R. Part 207


Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
Home | About Us | News | Resources | Exhibitions | Seminars | Associations | Careers | Sitemap | Terms of Use © 2014 Registrar Corp
 
Food and Beverages | Drugs | Cosmetics | Medical Devices | Radiation-Emitting Electronic Devices | Color Additives | Tobacco